Which Peptides Are FDA-Approved?
6 of the 16 peptides patients ask about most are FDA-approved finished drugs. The rest are compounded-only or still investigational. Here is the line between them, with verified approval years.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
FDA-approved peptides include semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide (Vyleesi), and insulin. Popular wellness peptides such as BPC-157, TB-500, sermorelin, CJC-1295, and ipamorelin are notFDA-approved as finished drugs. They are available, if at all, only through licensed compounding pharmacies under physician supervision. “Peptide” covers everything from decades-old insulin to experimental research compounds, so the useful question is always which peptide. The table below answers it.
The distinction matters because FDA approval is what stands behind a medication’s manufacturing purity, dosing accuracy, safety monitoring, and proven efficacy. Approved GLP-1 peptides like semaglutide and tirzepatidehave large, multi-year clinical trials behind them; unapproved “research” peptides typically do not. That does not make every unapproved peptide unsafe or illegitimate, but it does mean the evidence, oversight, and sourcing are different. That is why a physician should be involved rather than a checkout form.
This page is general medical information, not a prescription. If you are researching peptide therapy in Las Vegas or anywhere in Nevada, the next step is an evaluation with Dr. Charles Kamen, MD, in person at our southeast Las Vegas clinic at Eastern Avenue and the 215, or by secure telehealth, where the question becomes which option is appropriate for you.
FDA-Approved Peptides — The Full Reference Table
Note: More than 80 peptide drugs are FDA-approved overall (including insulin analogs, oxytocin, octreotide, and others); this table focuses on the peptides patients most often ask about in longevity and metabolic care. MK-677 (ibutamoren) is frequently grouped with peptides but is an orally active, non-peptide growth-hormone secretagogue, and it is also not FDA-approved.
How this list is maintained: compiled and reviewed by Charles Kamen, MD against two primary FDA sources — whether a compound is an approved finished drug (and its approval year) is checked in the FDA Drugs@FDA database, and the compounding pathway for unapproved peptides (e.g. BPC-157, TB-500) is checked against the FDA’s 503A bulk drug substances list. Regulatory status — especially for compounded peptides — changes over time and is verified at the time of care. For how that compounding framework works, see our explainers on the FDA peptide compounding status and the difference between 503A vs 503B compounding pharmacies.
Physician-Led in Las Vegas
Found a peptide on the list — not sure it’s right for you?
The table above is what the FDA has actually approved, but whether a given peptide is appropriate for you depends on your history, labs, and goals. A $88 evaluation with Dr. Charles Kamen, MD walks through which of these is evidence-supported for your situation — including whether an FDA-approved option like semaglutide or tirzepatide fits, or whether a compounded option like sermorelin or BPC-157 is appropriate.
FDA-Approved Drugs vs. “Research Peptides”
A lot of confusion comes from treating “peptides” as one category. They are not. An FDA-approved peptide drug, such as semaglutide, tirzepatide, or insulin, is a finished, manufactured medication that has passed the FDA’s review for safety, efficacy, manufacturing quality, and labeling, with a defined indication, dose, and safety-monitoring requirement. It comes from a regulated supply chain and is prescribed by a clinician for a specific person.
A “research peptide,” typically sold online and labeled “not for human consumption” or “for research use only,” is none of those things. It is not made to drug-grade standards, is not reviewed for safety or efficacy in people, and is not labeled with a real dose or indication. Buying BPC-157, TB-500, or any “research” GLP-1 from a website that ships you a vial and a syringe is not the same as receiving a compounded medication from a licensed pharmacy under physician supervision. The gap between those two is the gap between medicine and self-experimentation.
In between sits physician-supervised compounding, a legally defined pathway under FDA Sections 503A and 503B where licensed pharmacies prepare specific compounds for individual patients when an appropriate finished drug is not available. For peptides that are not FDA-approved but have a reasonable clinical rationale (sermorelin, CJC-1295, ipamorelin, and others), this is the only legitimate way they reach a patient, and it requires a prescription, a physician, and a pharmacy you can actually identify. For how we grade the evidence behind each of these, see our peptide evidence grades.
What This Means for Patients in Las Vegas
FDA-approved options (semaglutide, tirzepatide) are available now in Las Vegas after a physician evaluation and labs — no “research” vials, no guesswork.
Compounded-only peptides (sermorelin, CJC-1295, ipamorelin) require a prescription from a licensed Nevada clinician and a licensed 503A/503B pharmacy — not a website.
“Research use only” peptides sold online (BPC-157, TB-500, “research” GLP-1s) are not made for human use and carry real safety unknowns; we strongly recommend against them.
Retatrutide and other investigational peptides are not FDA-approved and cannot be dispensed as a prescription anywhere — including Las Vegas — while trials are ongoing.
Every plan at LiveNow Longevity starts with an $88 evaluation with Dr. Charles Kamen, MD — applied toward your plan if you continue, with medication at pharmacy pass-through cost.
Honesty over hype: if a peptide is not appropriate or not evidence-supported for you, Dr. Kamen will tell you — and tell you what is.
Serving Las Vegas, Henderson, Green Valley, and all of Nevada — in person at our clinic at Eastern Avenue and the 215, or by secure telehealth. See our Las Vegas peptide clinic for directions and booking.
FDA-Approval FAQ
Which peptides are FDA-approved?
The FDA-approved peptides most relevant to longevity and metabolic care are semaglutide, tirzepatide, liraglutide, tesamorelin, bremelanotide (Vyleesi), and insulin — with more than 80 peptide drugs FDA-approved overall. Many popular wellness peptides — BPC-157, TB-500, sermorelin, CJC-1295, ipamorelin — are NOT FDA-approved as finished drugs and are only available, if at all, through licensed compounding pharmacies under physician supervision.
Are peptides FDA-approved?
Some are; most are not. "Peptide" simply describes a short chain of amino acids — it covers everything from insulin (a peptide drug first approved in 1982) to experimental research compounds with no human trials. So the question is never "are peptides FDA-approved" in general; it is always whether the specific peptide has gone through the FDA approval process as a finished drug. The table above is the honest, peptide-by-peptide answer.
Is BPC-157 FDA-approved?
No — BPC-157 is not FDA-approved and has never been submitted for FDA approval. Most of its supporting research is in animal models. Its status under federal compounding rules has changed repeatedly through 2025–2026 and is under active FDA review, so its availability should be verified at the time of care rather than assumed.
Is PT-141 FDA-approved?
The active ingredient in PT-141 — bremelanotide — is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women (approved 2019). PT-141 sold outside that approved finished drug does not carry the same FDA-approved standing and is typically marketed for unapproved, off-label use.
Is retatrutide FDA-approved?
No — retatrutide is an investigational triple agonist (GIP/GLP-1/glucagon) still in late-stage clinical trials as of July 2026. It is not yet an FDA-approved finished drug and cannot be dispensed as a standard prescription anywhere, including Las Vegas. See our physician-reviewed retatrutide guide for the current trial status.
Is semaglutide a peptide, and is it FDA-approved?
Yes on both counts — semaglutide is a peptide (a GLP-1 receptor agonist) and it is FDA-approved, first approved as Ozempic for type 2 diabetes in 2017 and as Wegovy for chronic weight management in 2021. Tirzepatide (Mounjaro, 2022; Zepbound, 2023) is similarly a peptide and similarly FDA-approved. Neither should be confused with unapproved "research" peptides sold online.
Are compounded peptides FDA-approved?
No — compounded peptides are never "FDA-approved." Compounding is a separate legal pathway (under FDA Sections 503A and 503B) that lets licensed pharmacies prepare medications for individual patients when an appropriate finished drug is not available. It is overseen differently than drug approval and does not carry the same safety, efficacy, and manufacturing review. The compounding status of specific peptides (BPC-157, TB-500, and others) has shifted repeatedly through 2025–2026, which is why we verify it at the time of care.
Why are some peptides not FDA-approved?
A peptide is usually not FDA-approved for one of three reasons: no manufacturer has sponsored it through the approval process (most "wellness" peptides, because the patent and market economics do not justify the cost); the human clinical evidence is too thin to meet the FDA efficacy bar; or it is still in active clinical development (like retatrutide). "Not FDA-approved" is a regulatory status, not a safety verdict — but it does mean the evidence and oversight behind it are different, which is exactly why physician evaluation matters.
Does "not FDA-approved" mean a peptide is illegal or unsafe?
Not automatically — "not FDA-approved" means a peptide has not gone through the FDA's formal approval process for a finished drug. Some are still legally compounded for individual patients and used under medical supervision; others carry meaningful safety unknowns because human data is thin. The responsible approach is physician evaluation, licensed-pharmacy sourcing, and an honest discussion of what is proven versus experimental.
Why does FDA approval matter?
FDA approval matters because it means a medication's manufacturing, dosing, safety, and efficacy have been reviewed and are monitored. Approved peptides like the GLP-1s have large clinical trials behind them — for example, the STEP trials for semaglutide. Unapproved compounds can still have a legitimate role, but the evidence and oversight are different — which is exactly why a physician should be involved.
Related reading: 503A vs 503B compounding pharmacies · Is compounded semaglutide the same as Ozempic? · Do you need a prescription for peptides? · Is peptide therapy safe? · Retatrutide FDA status · Peptide regulatory status tracker
Selected Research
- Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002. (STEP 1: once-weekly semaglutide in adults with overweight or obesity.)
- Müller TD, et al. Mol Metab. 2019;30:72-130. (Glucagon-like peptide 1 (GLP-1): physiology, satiety, and metabolism.)
- Cerovecki T, et al. J Orthop Res. 2010;28(9):1155-1161. (BPC-157 and ligament healing in the rat.)
- King R, Tuthill C. Vitam Horm. 2016;102:151-178. (Immune modulation with thymosin alpha-1 treatment.)
Background mechanistic and clinical-trial sources only. Not a treatment claim. Approval status on this page reflects U.S. FDA finished-drug approval and is verified against FDA Drugs@FDA; individual results vary and any decision belongs with a physician after evaluation.
Physician-Led in Las Vegas
Not sure what’s right — or real — for you?
A board-certified neurologist will tell you honestly which options are FDA-approved, which are compounded, and what the evidence actually supports for your goals — including whether an FDA-approved option like tirzepatide or semaglutide fits you.
Ready to start your longevity care?
Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.
Book Your $88 EvaluationPrefer to talk? Call (702) 808-2650 or text us to book.
Physician-led peptide therapy in Las Vegas. Visit our clinicAlso serving Henderson — or explore semaglutide weight loss in Las Vegas.